Hypochondroplasia Explained

Hypochondroplasia
Symptoms:Skeletal dysplasia
Causes:FGFR3 gene mutation
Diagnosis:Physical finding, X-ray
Treatment:Special education, Laminectomy

Hypochondroplasia (HCH) is a developmental disorder caused by an autosomal dominant genetic defect in the fibroblast growth factor receptor 3 gene (FGFR3) that results in a disproportionately short stature, micromelia[1] and a head that appears large in comparison with the underdeveloped portions of the body. It is classified as short-limbed dwarfism.[2] [3]

Signs and symptoms

Individuals affected by this disorder appear normal at birth. As the infant grows, however, their arms and legs do not develop properly, and their body becomes thicker and shorter than normal.[1] The following are characteristics consistent with this condition:[4]

Cause

Hypochondroplasia is inherited as an autosomal dominant trait affecting the FGFR3 gene on chromosome 4p16.3. There is currently no cure for this condition.[2]

Pathophysiology

This disorder results from mutations in the proximal tyrosine kinase domain of the FGFR3 gene.[1] This gene plays an important role in embryonic development, helping to regulate activities such as cell division, migration and differentiation.[5]

Hypochondroplasia can be caused by point mutations such as p. Lys650Asn.[6] [1] In FGFR3, some 20 different mutations have been associated with hypochondroplasia,[7] and it seems to have a role in skeletal dysplasia.[8]

Diagnosis

The diagnosis of this condition can be done via X-rays (with lack of normal distance L1 to L5),[9] and additionally genetic testing is available to ascertain hypochondroplasia.[10] However, the physical characteristics are one of the most important in determining the condition.[1]

Treatment

Treatment of hypochondroplasia usually takes the form of orthopedic surgery and physical therapy. Genetic counseling is advised for individuals and their families. Specifically in the case of spinal stenosis, one option is laminectomy.[1] [4]

Prognosis

Life expectancy for individuals with hypochondroplasia is normal; height is about 132cm-147cmcm (52inches-58inchescm).[11]

See also

Further reading

Notes and References

  1. Bober. Michael B.. Bellus. Gary A.. Nikkel. Sarah M.. Tiller. George E.. Hypochondroplasia. GeneReviews. 1 January 1993. 20301650. 18 December 2016. update 2013
  2. Web site: Hypochondroplasia - Genetics Home Reference . 2009-03-12.
  3. Web site: Dwarfism: MedlinePlus. NIH. 21 December 2016.
  4. Web site: Hypochondroplasia Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. rarediseases.info.nih.gov. 21 December 2016.
  5. Web site: Entry - *134934 - FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3 - OMIM - (MIRROR) . 2023-02-28 . mirror.omim.org.
  6. Web site: NM_000142.4(FGFR3):c.1950G>C (p.Lys650Asn) AND Hypochondroplasia - ClinVar - NCBI. www.ncbi.nlm.nih.gov. 21 December 2016.
  7. Web site: Reference. Genetics Home. FGFR3 gene. Genetics Home Reference. 21 December 2016.
  8. Foldynova-Trantirkova . Silvie . Wilcox . William R. . Krejci . Pavel . Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias . Human Mutation . 21 December 2016 . 33 . 1 . 29–41 . 10.1002/humu.21636. 3240715 . 1059-7794 . 22045636.
  9. Web site: OMIM Entry - # 146000 - HYPOCHONDROPLASIA; HCH. omim.org. 21 December 2016.
  10. Web site: Hypochondroplasia - Conditions - GTR - NCBI. www.ncbi.nlm.nih.gov. 21 December 2016.
  11. Web site: RESERVED. INSERM US14 -- ALL RIGHTS. Orphanet: Hypochondroplasia. www.orpha.net. 21 December 2016.